SEQURNA
LIVE

Serial Number

79398350

Owner

Sequrna AB

Attorney

Thomas Y. Yee

Filing Date

Feb 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SEQURNA Trademark

Serial Number: 79398350 • Registration: 7830597

SEQURNA is a trademark filed by Sequrna AB on February 13, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Sequrna AB (2 trademarks)

Ekvägen 4

Entity Type: 99

SEQURNA AB

Fogdevreten 2
SOLNA 171 65 , SE

Entity Type: 64

Trademark Details

Filing Date

February 13, 2024

Registration Date

June 17, 2025

Published for Opposition

April 29, 2025

Goods & Services

Scientific, medical and pharmaceutical research and development services; scientific laboratory services; medical research laboratory services; laboratory research services relating to molecular biology and biomedicine; medical and scientific consulting services in the fields of molecular biology and biomedicine; providing medical and scientific research information in the field of molecular biology and biomedicine; pharmaceutical and scientific research and development; laboratory diagnostics, namely, medical analysis services relating to the diagnosis and treatment of persons provided by medical laboratories; medical and scientific information, advisory and consultancy services relating to the aforesaid

Reagents for medical research; diagnostic reagents for scientific use; reagents for research purposes.

Reagents for medical use; clinical diagnostic reagents for medical use; diagnostic reagents for medical use; reagents for use with analyzers for medical purposes; diagnostic biomarker reagents for medical purposes; clinical medical reagents; reagent paper for medical purposes; RNase inhibitors for medical purposes

Medical instruments, namely, vials containing RNase inhibitors used for RNA sequencing; instruments for use in medical analysis, namely, vials containing RNase inhibitors used for RNA sequencing; testing instruments for medical purposes, namely, vials containing RNase inhibitors used for RNA sequencing; diagnostic instruments for medical purposes, namely, vials containing RNase inhibitors used for RNA sequencing; apparatus for DNA and RNA exams for medical purposes; capillary tubes for delivering reagents for medical use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 5, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 16, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 16, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 26, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 17, 2025 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 19, 2025 ADCH
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 17, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 31, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 31, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 20, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 20, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 20, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 20, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 20, 2024 COAR
REFUSAL PROCESSED BY IB
Oct 7, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 14, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 12, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 11, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 5, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 28, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 27, 2024 REPR